全部

 +
Citation
318 条搜索结果 for EGFR
An albumin‑binding domain and targeting peptide‑based recombinant protein and its enediyne‑integrated analogue exhibit directional delivery and potent inhibitory activity on pancreatic cancer with K‑ras mutation
Authors: Sheng W, Geng J, Li L, Shang Y, Jiang M, Zhen Y.
Journal: Oncol Rep
PubMed ID: 32020213
Products & Services: Gene Synthesis   
EPS8L3 promotes hepatocellular carcinoma proliferation and metastasis by modulating EGFR dimerization and internalization
Authors: Xuan Z, , , Zhao L, , , Li Z, , , Song W, , , Chen J, , , Chen J, , , Chen H, , , Song G, , , Jin C, , , Zhou M, , , Xie H, , , Zheng S, , , Song P, , .
Journal: Am J Cancer Res
PubMed ID: 32064153
Products & Services: Proteins, Expression, Isolation and Analysis   
Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα "don't eat me" immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation
Authors: Mark A J M Hendriks, Emily M Ploeg, Iris Koopmans, Isabel Britsch, Xiurong Ke, Douwe F Samplonius, Wijnand Helfrich
Journal: Oncoimmunology
PubMed ID: 33299654
Doi: 10.1080/2162402X.2020.1824323
Products & Services: Gene Synthesis   
Identification of a novel anti-EGFR nanobody by phage display and its distinct paratope and epitope via homology modeling and molecular docking
Authors: Xi Xi, Weihan Sun, Hang Su, Xitian Zhang, Fei Sun
Journal: Mol Immunol
PubMed ID: 33130376
Doi: 10.1016/j.molimm.2020.10.014
Products & Services: GenParts™ DNA Fragments   
Circulating tumor DNA analysis of EGFR-mutant non-small cell lung cancer patients receiving osimertinib following previous tyrosine kinase inhibitor treatment
Authors: Jamie J Beagan, Sander Bach, Robert A van Boerdonk, Erik van Dijk, Erik Thunnissen, Daan van den Broek, Janneke Weiss, Geert Kazemier, D Michiel Pegtel, Idris Bahce, Bauke Ylstra, Daniëlle A M Heideman
Journal: Lung Cancer
PubMed ID: 32460198
Doi: 10.1016/j.lungcan.2020.04.039
Products & Services: Molecular Biology Reagents   
Defining the landscape of ATP-competitive inhibitor resistance residues in protein kinases.
Authors: Persky NS, Hernandez D, Do Carmo M, Brenan L, Cohen O,,,, Kitajima S, Nayar U,,,, Walker A, Pantel S, Lee Y, Cordova J, Sathappa M, Zhu C, Hayes TK,, Ram P,,,, Pancholi P, Mikkelsen TS,,, Barbie DA, Yang X, Haq R, Piccioni F, Root DE, Johannessen CM,.
Journal: NATURE STRUCTURAL & MOLECULAR BIOLOGY
PubMed ID: 31925410
Products & Services: Gene Synthesis   
LINC00152 Knock-down Suppresses Esophageal Cancer by EGFR Signaling Pathway
Authors: Ding Y, Guo H, Zhu L, Xu L, Pei Q, Cao Y
Journal: Open medicine (Warsaw, Poland)
PubMed ID: 32190735
Doi: 10.1515/med-2020-0019
Products & Services: Catalog Antibody   
Point mutations in retargeted gD eliminate the sensitivity of EGFR/EGFRvIII-targeted HSV to key neutralizing antibodies
Authors: Tuzmen C, Cairns TM, Atanasiu D, Lou H, Saw WT, Hall BL, Cohen JB, Cohen GH, Glorioso JC.
Journal: Mol Ther Methods Clin Dev
PubMed ID: 32042851
Doi: 10.1016/j.omtm.2019.12.013
Products & Services: Codon Optimization   
Multi-functional self-assembled nanoparticles for pVEGF-shRNA loading and anti-tumor targeted therapy
Authors: Lu S, Bao X, Hai W, Shi S, Chen Y, Yu Q, Zhang M, Xu Y, Peng J.
Journal: Int J Pharm
PubMed ID: 31846730
Products & Services: Peptide Synthesis   
KLF4 p.A472D Mutation Contributes to Acquired Resistance to Cetuximab in Colorectal Cancer.
Authors: Ye S, Hu X, Ni C, Jin W, Xu Y, Chang L, Zhou H, Jiang J, Yang L.
Journal: Mol Cancer Ther
PubMed ID: 31924740
Products & Services: Custom Vector Construction